Metabolic Syndrome Clinical Trial
Official title:
Habit Design: Testing a Novel Behavioral Approach to Corporate Wellness in the Context of Metabolic Syndrome
Verified date | November 2022 |
Source | Habit Design |
Contact | Susan Stoner, PhD |
Phone | 2065434520 |
sastoner[@]uw.edu | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A randomized controlled trial will be conducted to evaluate the effectiveness of the Habit Design (HD) approach in a corporate health context over the course of one year in subjects with metabolic syndrome. All subjects will be coached to increase physical activity. Additionally, subjects will choose and be coached to achieve a goal of either increasing fruit and vegetable intake or substituting water for sugar-sweetened beverages. Subjects will be randomly assigned to receive either standard coaching (control condition) or HD-enhanced coaching (experimental condition).
Status | Recruiting |
Enrollment | 424 |
Est. completion date | December 2024 |
Est. primary completion date | April 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: 1. Participant in TriHealth's Corporate Wellness Program completing voluntary Personal Health Assessment, including screening for metabolic syndrome. 2. Meet at least 3/5 criteria for metabolic syndrome: - elevated triglycerides (=150 mg/dL), - insufficient high-density lipoprotein cholesterol (<40 mg/dL in males and <50 mg/dL in females) - elevated blood pressure (systolic =130 and/or diastolic =85 mm Hg) - elevated fasting blood glucose (=100 mg/dl) - above-threshold waist circumference (=102 cm in males and =80 cm in females) 3. Interested in increasing physical activity and fruit/vegetable or water intake 4. Own a compatible smartphone (iOS or Android) and willing/able to use it for the study Exclusion Criteria: - Have medical or other contraindications to increasing physical activity or fruit/vegetable/water intake |
Country | Name | City | State |
---|---|---|---|
United States | TriHealth | Cincinnati | Ohio |
Lead Sponsor | Collaborator |
---|---|
Habit Design | TriHealth Inc., University of Washington |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline average daily step count at 16 weeks | Fitbit data will be monitored using the Fitabase platform. | 16 weeks | |
Primary | Change from baseline average daily step count at 32 weeks | Fitbit data will be monitored using the Fitabase platform. | 32 weeks | |
Primary | Change from baseline average daily step count at 48 weeks | Fitbit data will be monitored using the Fitabase platform. | 48 weeks | |
Secondary | Change in frequency consuming fruits and vegetables in the past 4 months at 16 weeks | Self-reported food frequency data derived from the Diet History Questionnaire-III. Fifteen items for fruits and fifteen items for vegetables will be rated on a scale from 0-9 and a sum of the item scores will be computed. Minimum: 0, Maximum: 270. Higher numbers are better. | 16 weeks | |
Secondary | Change in frequency consuming fruits and vegetables in the past 4 months at 32 weeks | Self-reported food frequency data derived from the Diet History Questionnaire-III. Fifteen items for fruits and fifteen items for vegetables will be rated on a scale from 0-9 and a sum of the item scores will be computed. Minimum: 0, Maximum: 270. Higher numbers are better. | 32 weeks | |
Secondary | Change in frequency consuming fruits and vegetables in the past 4 months at 48 weeks | Self-reported food frequency data derived from the Diet History Questionnaire-III. Fifteen items for fruits and fifteen items for vegetables will be rated on a scale from 0-9 and a sum of the item scores will be computed. Minimum: 0, Maximum: 270. Higher numbers are better. | 48 weeks | |
Secondary | Change in frequency consuming water in the past 4 months at 16 weeks | Self-reported food frequency data derived from the Diet History Questionnaire-III. Two items for water will be rated on a scale from 0-9 and a sum of the item scores will be computed. Minimum: 0, Maximum: 18. Higher numbers are better. | 16 weeks | |
Secondary | Change in frequency consuming water in the past 4 months at 32 weeks | Self-reported food frequency data derived from the Diet History Questionnaire-III. Two items for water will be rated on a scale from 0-9 and a sum of the item scores will be computed. Minimum: 0, Maximum: 18. Higher numbers are better. | 32 weeks | |
Secondary | Change in frequency consuming water in the past 4 months at 48 weeks | Self-reported food frequency data derived from the Diet History Questionnaire-III. Two items for water will be rated on a scale from 0-9 and a sum of the item scores will be computed. Minimum: 0, Maximum: 18. Higher numbers are better. | 48 weeks | |
Secondary | Change in baseline triglycerides at 16 weeks | Triglycerides will be measured using standard laboratory procedures. | 16 weeks | |
Secondary | Change in baseline triglycerides at 32 weeks | Triglycerides will be measured using standard laboratory procedures. | 32 weeks | |
Secondary | Change in baseline triglycerides at 48 weeks | Triglycerides will be measured using standard laboratory procedures. | 48 weeks | |
Secondary | Change in baseline fasting blood glucose at 16 weeks | Fasting blood glucose will be measured using standard laboratory procedures. | 16 weeks | |
Secondary | Change in baseline fasting blood glucose at 32 weeks | Fasting blood glucose will be measured using standard laboratory procedures. | 32 weeks | |
Secondary | Change in baseline fasting blood glucose at 48 weeks | Fasting blood glucose will be measured using standard laboratory procedures. | 48 weeks | |
Secondary | Change in baseline blood pressure at 16 weeks | Systolic and diastolic blood pressure will be measured using standard procedures. | 16 weeks | |
Secondary | Change in baseline blood pressure at 32 weeks | Systolic and diastolic blood pressure will be measured using standard procedures. | 32 weeks | |
Secondary | Change in baseline blood pressure at 48 weeks | Systolic and diastolic blood pressure will be measured using standard procedures. | 48 weeks | |
Secondary | Change in baseline waist circumference at 16 weeks | Waist circumference will be measured using standard procedures. | 16 weeks | |
Secondary | Change in baseline waist circumference at 32 weeks | Waist circumference will be measured using standard procedures. | 32 weeks | |
Secondary | Change in baseline waist circumference at 48 weeks | Waist circumference will be measured using standard procedures. | 48 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04635202 -
Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome
|
N/A | |
Completed |
NCT05343858 -
Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome
|
N/A | |
Completed |
NCT04053686 -
An Intervention to Reduce Prolonged Sitting in Police Staff
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Recruiting |
NCT05040958 -
Carotid Atherosclerotic Plaque Load and Neck Circumference
|
||
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Completed |
NCT03289897 -
Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan
|
N/A | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Completed |
NCT06057896 -
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
|
||
Active, not recruiting |
NCT03613740 -
Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
|
Phase 2 | |
Completed |
NCT04498455 -
Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency
|
Phase 4 | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT03697382 -
Effect of Daily Steps on Fat Metabolism
|
N/A | |
Completed |
NCT03241121 -
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome
|
N/A | |
Completed |
NCT04509206 -
Virtual Teaching Kitchen
|
N/A | |
Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A |